Biotech Goosed Stock With Omicron Vax Claims, Suit Says
An investor in the biotech company formerly known as Adagio Therapeutics Inc. filed suit Monday in Boston federal court, claiming executives made empty boasts about its COVID-19 vaccine and caused the...To view the full article, register now.
Already a subscriber? Click here to view full article